OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Apolipoprotein E: Structural Insights and Links to Alzheimer Disease Pathogenesis
Yun Chen, Michael R. Strickland, Andrea Soranno, et al.
Neuron (2020) Vol. 109, Iss. 2, pp. 205-221
Open Access | Times Cited: 199

Showing 1-25 of 199 citing articles:

White matter aging drives microglial diversity
Shima Safaiyan, Simon Besson‐Girard, Tuğberk Kaya, et al.
Neuron (2021) Vol. 109, Iss. 7, pp. 1100-1117.e10
Open Access | Times Cited: 308

Astrocyte-neuron metabolic cooperation shapes brain activity
Gilles Bonvento, Juan P. Bolaños
Cell Metabolism (2021) Vol. 33, Iss. 8, pp. 1546-1564
Open Access | Times Cited: 305

Microglia in Alzheimer's disease at single-cell level. Are there common patterns in humans and mice?
Yun Chen, Marco Colonna
The Journal of Experimental Medicine (2021) Vol. 218, Iss. 9
Open Access | Times Cited: 241

ApoE Cascade Hypothesis in the pathogenesis of Alzheimer’s disease and related dementias
Yuka A. Martens, Na Zhao, Chia‐Chen Liu, et al.
Neuron (2022) Vol. 110, Iss. 8, pp. 1304-1317
Open Access | Times Cited: 213

Challenges and hopes for Alzheimer’s disease
Suren A. Tatulian
Drug Discovery Today (2022) Vol. 27, Iss. 4, pp. 1027-1043
Closed Access | Times Cited: 201

The biology of TREM receptors
Marco Colonna
Nature reviews. Immunology (2023) Vol. 23, Iss. 9, pp. 580-594
Open Access | Times Cited: 187

Cholesterol and Alzheimer’s Disease; From Risk Genes to Pathological Effects
Femke M. Feringa, Rik van der Kant
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 169

APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer’s disease pathology and brain diseases
Rosalía Fernández‐Calle, Sabine C. Konings, Javier Frontiñán-Rubio, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 142

APOE mediated neuroinflammation and neurodegeneration in Alzheimer’s disease
Samira Parhizkar, David M. Holtzman
Seminars in Immunology (2022) Vol. 59, pp. 101594-101594
Open Access | Times Cited: 132

Transgenic Mouse Models of Alzheimer’s Disease: An Integrative Analysis
Raquel Sánchez‐Varo, Marina Mejias‐Ortega, Juan José Fernandez-Valenzuela, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5404-5404
Open Access | Times Cited: 81

Multifaceted roles of APOE in Alzheimer disease
Rosemary J. Jackson, Bradley T. Hyman, Alberto Serrano‐Pozo
Nature Reviews Neurology (2024) Vol. 20, Iss. 8, pp. 457-474
Closed Access | Times Cited: 35

The interaction between ageing and Alzheimer's disease: insights from the hallmarks of ageing
Yuqing Liu, Yejun Tan, Zheyu Zhang, et al.
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 30

Mitochondria in Alzheimer’s Disease Pathogenesis
Allison B. Reiss, Shelly Gulkarov, Benna Jacob, et al.
Life (2024) Vol. 14, Iss. 2, pp. 196-196
Open Access | Times Cited: 26

APOE traffics to astrocyte lipid droplets and modulates triglyceride saturation and droplet size
Ian A. Windham, Alex E. Powers, Joey V. Ragusa, et al.
The Journal of Cell Biology (2024) Vol. 223, Iss. 4
Open Access | Times Cited: 22

An aging-related immune landscape in the hematopoietic immune system
Jianjie Lv, Chun Zhang, Xiuxing Liu, et al.
Immunity & Ageing (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 17

Targeting dysregulated lipid metabolism for the treatment of Alzheimer's disease and Parkinson's disease: Current advancements and future prospects
Bin Tong, Yaoqi Ba, Zhengyang Li, et al.
Neurobiology of Disease (2024) Vol. 196, pp. 106505-106505
Open Access | Times Cited: 17

Co-aggregation with Apolipoprotein E modulates the function of Amyloid-β in Alzheimer’s disease
Zengjie Xia, Emily E. Prescott, Agnieszka Urbanek, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 17

Inflammatory Cascade in Alzheimer’s Disease Pathogenesis: A Review of Experimental Findings
Jade de Oliveira, Ewa Kucharska, Michelle Lima Garcez, et al.
Cells (2021) Vol. 10, Iss. 10, pp. 2581-2581
Open Access | Times Cited: 63

Potential of Caffeine in Alzheimer’s Disease—A Review of Experimental Studies
Piotr Londzin, Milena Zamora, Beata Kąkol, et al.
Nutrients (2021) Vol. 13, Iss. 2, pp. 537-537
Open Access | Times Cited: 60

The COVID-19 pandemic and Alzheimer’s disease: mutual risks and mechanisms
Feng Chen, Yan‐Ting Chen, Yongxiang Wang, et al.
Translational Neurodegeneration (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 45

The Role of Astrocytes in Synapse Loss in Alzheimer's Disease: A Systematic Review
Lianne A. Hulshof, Danny van Nuijs, Elly M. Hol, et al.
Frontiers in Cellular Neuroscience (2022) Vol. 16
Open Access | Times Cited: 39

Cholesterol Metabolism in Aging and Age-Related Disorders
Gesine Saher
Annual Review of Neuroscience (2023) Vol. 46, Iss. 1, pp. 59-78
Open Access | Times Cited: 33

Clinical considerations in early-onset cerebral amyloid angiopathy
Gargi Banerjee, John Collinge, Nick C. Fox, et al.
Brain (2023) Vol. 146, Iss. 10, pp. 3991-4014
Open Access | Times Cited: 26

Insights on benzodiazepines' potential in Alzheimer's disease
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Abdulrahman A. Alsayegh, et al.
Life Sciences (2023) Vol. 320, pp. 121532-121532
Closed Access | Times Cited: 24

Page 1 - Next Page

Scroll to top